Literature DB >> 8976655

Head growth in cystic fibrosis following early diagnosis by neonatal screening.

S Ghosal1, C J Taylor, M Pickering, J McGaw.   

Abstract

Growth in length, weight gain, and head circumference were recorded from 3 months to 4 years of age in 25 children with cystic fibrosis diagnosed by neonatal screening. Mean standard deviation (SD) scores at 3 months for length, weight, and head circumference were -0.78, -0.91, and -0.52 respectively. Over the first 2 years length SD scores showed a consistent improvement and stabilised at 0.1 SD below mean from 2 to 4 years. Weight SD scores remained essentially unaltered throughout, approximately 1 SD below the mean. Head circumference, however, after an initial increase from -0.52 at 3 months to -0.25 at 18 months, slowed and fell to 1 SD below the mean at 4 years. The data suggest that head growth continues to lag behind somatic growth in children with cystic fibrosis despite early diagnosis and good nutritional management in early infancy. These data also support functional expression of cystic fibrosis transmembrane conductance regulator in the brain.

Entities:  

Mesh:

Year:  1996        PMID: 8976655      PMCID: PMC1511694          DOI: 10.1136/adc.75.3.191

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Effect of infantile malnutrition on growth.

Authors:  G G Graham
Journal:  Fed Proc       Date:  1967 Jan-Feb

2.  Principles of screening for disease.

Authors:  J M Wilson
Journal:  Proc R Soc Med       Date:  1971-12

3.  Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis.

Authors:  M N Bronstein; R J Sokol; S H Abman; B A Chatfield; K B Hammond; K M Hambidge; C D Stall; F J Accurso
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

4.  Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.

Authors:  E Ranieri; R G Ryall; C P Morris; P V Nelson; W F Carey; A C Pollard; E F Robertson
Journal:  BMJ       Date:  1991-05-25

5.  Reduced morbidity in patients with cystic fibrosis detected by neonatal screening.

Authors:  B Wilcken; G Chalmers
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

6.  Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain.

Authors:  A E Mulberg; L P Resta; E B Wiedner; S M Altschuler; D M Jefferson; D L Broussard
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  An animal model for cystic fibrosis made by gene targeting.

Authors:  J N Snouwaert; K K Brigman; A M Latour; N N Malouf; R C Boucher; O Smithies; B H Koller
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

8.  Cystic fibrosis in the mouse by targeted insertional mutagenesis.

Authors:  J R Dorin; P Dickinson; E W Alton; S N Smith; D M Geddes; B J Stevenson; W L Kimber; S Fleming; A R Clarke; M L Hooper
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

9.  Somatomedin activity in cystic fibrosis and reserpinized rats: possible explanation for growth retardation.

Authors:  J A Lee; L S Dickinson; B S Kilgore; R H Warren; M J Elders
Journal:  Ann Clin Lab Sci       Date:  1980 May-Jun       Impact factor: 1.256

10.  Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.

Authors:  S Chatfield; G Owen; H C Ryley; J Williams; M Alfaham; M C Goodchild; P Weller
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.